12 Health Care Stocks Moving In Wednesday's Intraday Session
Portfolio Pulse from Benzinga Insights
The article highlights significant intraday movements in health care stocks on Wednesday. Notable gainers include SINTX Technologies, T2 Biosystems, Nutriband, Bone Biologics, OptimizeRx, and Eyenovia. On the losing side, Virpax Pharmaceuticals, Aethlon Medical, Yield10 Bioscience, Bolt Biotherapeutics, Oncology Institute, and TRACON Pharma saw substantial declines.
May 15, 2024 | 4:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aethlon Medical stock fell by 50.35% to $0.42, indicating a strong negative market reaction.
The significant price drop suggests a strong negative market reaction, possibly due to recent news or earnings.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Bolt Biotherapeutics shares declined by 33.12% to $0.88 following the release of their Q1 earnings report.
The price drop is likely due to a negative market reaction to the company's Q1 earnings report.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75
NEGATIVE IMPACT
TRACON Pharma shares declined by 18.27% to $1.61 following the release of their Q1 earnings report.
The price drop is likely due to a negative market reaction to the company's Q1 earnings report.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75
NEGATIVE IMPACT
Oncology Institute shares fell by 18.91% to $0.73 following the release of their Q1 earnings report.
The price drop is likely due to a negative market reaction to the company's Q1 earnings report.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75
NEGATIVE IMPACT
Virpax Pharmaceuticals stock decreased by 67.0% to $0.76 following their Q1 earnings report.
The significant price drop is likely due to a negative market reaction to the company's Q1 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Yield10 Bioscience stock decreased by 37.84% to $3.27, reflecting negative market sentiment.
The price drop indicates negative market sentiment, possibly due to recent news or earnings.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Bone Biologics shares rose by 25.64% to $2.89 following the release of their Q1 earnings report.
The price increase is likely due to a positive market reaction to the company's Q1 earnings report.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Eyenovia shares rose by 20.57% to $1.0 following the release of their Q1 earnings report.
The price increase is likely due to a positive market reaction to the company's Q1 earnings report.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Nutriband shares increased by 25.9% to $4.67, reflecting positive market sentiment.
The price increase indicates positive market sentiment, possibly due to recent news or earnings.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
OptimizeRx shares increased by 22.8% to $12.87, likely driven by positive Q1 earnings.
The price increase is likely due to a positive market reaction to the company's Q1 earnings report.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
SINTX Technologies saw a significant 136.2% increase in stock price to $0.13, likely driven by recent Q1 earnings.
The substantial price increase is likely due to positive market reaction to the company's Q1 earnings report.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
T2 Biosystems shares rose by 45.55% to $6.06, indicating strong investor interest.
The significant price increase suggests strong investor interest, possibly due to recent developments or earnings.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80